ALZN   $1.12  -3.45% Market Open

Alzamend Neuro Inc
Total Cash 1.19M
totalCashPerShare 0.307
EBITDA -7.32M
Total Debt 0.00
quickRatio 0.414
currentRatio 0.491
Total Revenue
debtToEquity
Revenue/Share
ROA -2.1447098
ROE
grossProfits
freeCashflow -3.36M
operatingCashflow -6.03M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.45M
forwardPE -0.1283186
floatShares 3.78M
sharesOutstanding 4.48M
sharesShort 228.36K
sharesShortPriorMonth 69.81K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.90%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue -1.407
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -7.39M
trailingEps -142.87%
forwardEps -11.30%
enterpriseToEbitda -0.61
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.38 4Q 2024
institutionsCount 16
lastUpdated Nov. 7, 2024, 5:06 a.m.